ENDOCARE INC·4

Mar 14, 9:03 PM ET

ENDOCARE INC 4

4 · ENDOCARE INC · Filed Mar 14, 2005

Insider Transaction Report

Form 4
Period: 2005-03-10
DAVENPORT CRAIG T
DirectorChairman & CEO
Transactions
  • Purchase

    Series A Warrants (Right to Buy)

    2005-03-10+23,37523,375 total
    Exercise: $3.50Exp: 2010-03-11Common Stock (23,375 underlying)
  • Purchase

    Series B Warrants (Right to Buy)

    2005-03-10+23,37523,375 total
    Exercise: $4.00Exp: 2010-03-11Common Stock (23,375 underlying)
  • Purchase

    Common Stock

    2005-03-10$2.77/sh+66,787$185,00066,787 total
Footnotes (3)
  • [F1]Acquired in connection with the $15.6 million private placement financing that the Company closed on March 11, 2005.
  • [F2]The warrants were acquired for no additional consideration in connection with the purchase of shares of Common Stock at $2.77 per share in the financing referred to above.
  • [F3]Immediately.

Documents

1 file
  • 4
    biv06882_biv2ctd.xmlPrimary

    MAIN DOCUMENT DESCRIPTION